These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

373 related items for PubMed ID: 16127000

  • 1. Immunosuppressive therapy and clinical evolution in forty-nine patients with antineutrophil cytoplasmic antibody-associated glomerulonephritis.
    Kokolina E, Alexopoulos E, Dimitriadis C, Vainas A, Giamalis P, Papagianni A, Ekonomidou D, Memmos D.
    Ann N Y Acad Sci; 2005 Jun; 1051():597-605. PubMed ID: 16127000
    [Abstract] [Full Text] [Related]

  • 2. [ANCA-associated vasculitis].
    Sinico RA, Sabadini E, Boeri R, Radice A.
    G Ital Nefrol; 2002 Jun; 19(2):125-36. PubMed ID: 12195410
    [Abstract] [Full Text] [Related]

  • 3. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity.
    Vizjak A, Rott T, Koselj-Kajtna M, Rozman B, Kaplan-Pavlovcic S, Ferluga D.
    Am J Kidney Dis; 2003 Mar; 41(3):539-49. PubMed ID: 12612976
    [Abstract] [Full Text] [Related]

  • 4. Antineutrophil cytoplasmic antibody-associated glomerulonephritis in Taiwanese.
    Hung PH, Chiang WC, Chen YM, Lin SL, Lin WC, Tsai TJ, Chen WY.
    Nephrology (Carlton); 2004 Oct; 9(5):297-303. PubMed ID: 15504142
    [Abstract] [Full Text] [Related]

  • 5. Positive classic antineutrophil cytoplasmic antibody (C-ANCA) titer at switch to azathioprine therapy associated with relapse in proteinase 3-related vasculitis.
    Slot MC, Tervaert JW, Boomsma MM, Stegeman CA.
    Arthritis Rheum; 2004 Apr 15; 51(2):269-73. PubMed ID: 15077271
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of prognostic factors for myeloperoxidase anti-neutrophil cytoplasmic antibody- (MPO-ANCA) associated glomerulonephritis.
    Okano K, Yumura W, Nitta K, Honda K, Uchida K, Nihei H.
    Clin Nephrol; 2001 Apr 15; 55(4):275-81. PubMed ID: 11334312
    [Abstract] [Full Text] [Related]

  • 7. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.
    Rutgers A, Slot M, van Paassen P, van Breda Vriesman P, Heeringa P, Tervaert JW.
    Am J Kidney Dis; 2005 Aug 15; 46(2):253-62. PubMed ID: 16112043
    [Abstract] [Full Text] [Related]

  • 8. Crescentic glomerulonephritis in Wegener's granulomatosis: morphology, therapy, outcome.
    Grotz W, Wanner C, Keller E, Böhler J, Peter HH, Rohrbach R, Schollmeyer P.
    Clin Nephrol; 1991 Jun 15; 35(6):243-51. PubMed ID: 1873937
    [Abstract] [Full Text] [Related]

  • 9. ANCA-associated vasculitis with renal involvement: an outcome analysis.
    Weidner S, Geuss S, Hafezi-Rachti S, Wonka A, Rupprecht HD.
    Nephrol Dial Transplant; 2004 Jun 15; 19(6):1403-11. PubMed ID: 15069175
    [Abstract] [Full Text] [Related]

  • 10. Pauci-immune necrotizing glomerulonephritis.
    Rutgers A, Sanders JS, Stegeman CA, Kallenberg CG.
    Rheum Dis Clin North Am; 2010 Aug 15; 36(3):559-72. PubMed ID: 20688250
    [Abstract] [Full Text] [Related]

  • 11. Treatment of ANCA-associated systemic vasculitis.
    Belmont HM.
    Bull NYU Hosp Jt Dis; 2006 Aug 15; 64(1-2):60-6. PubMed ID: 17121492
    [Abstract] [Full Text] [Related]

  • 12. ANCA glomerulonephritis and vasculitis: a Chapel Hill perspective.
    Falk RJ, Nachman PH, Hogan SL, Jennette JC.
    Semin Nephrol; 2000 May 15; 20(3):233-43. PubMed ID: 10855933
    [Abstract] [Full Text] [Related]

  • 13. Prediction of relapses in PR3-ANCA-associated vasculitis by assessing responses of ANCA titres to treatment.
    Sanders JS, Huitma MG, Kallenberg CG, Stegeman CA.
    Rheumatology (Oxford); 2006 Jun 15; 45(6):724-9. PubMed ID: 16399845
    [Abstract] [Full Text] [Related]

  • 14. An index for renal outcome in ANCA-associated glomerulonephritis.
    Vergunst CE, van Gurp E, Hagen EC, van Houwelingen HC, Hauer HA, Noël LH, Waldherr R, Ferrario F, van der Woude FJ, Bruijn JA, Bajema IM, EC/BCR Project for ANCA-Assay Standardisation.
    Am J Kidney Dis; 2003 Mar 15; 41(3):532-8. PubMed ID: 12612975
    [Abstract] [Full Text] [Related]

  • 15. [Clinical analysis of 14 patients with anti-myeloperoxidase antibody positive rapid progressive glomerulonephritic syndrome].
    Hiromura K, Kitahara T, Kuroiwa T, Hayashi J, Tsukada Y, Kanai H, Maezawa A, Kawai H, Yano S, Naruse T.
    Nihon Jinzo Gakkai Shi; 1995 Oct 15; 37(10):573-9. PubMed ID: 7474510
    [Abstract] [Full Text] [Related]

  • 16. The role ANCA and anti-GBM antibodies in pulmonary-renal syndrome due to Wegener's granulomatosis.
    Zycinska K, Wardyn KA, Zielonka TM, Otto M.
    J Physiol Pharmacol; 2007 Nov 15; 58 Suppl 5(Pt 2):839-46. PubMed ID: 18204198
    [Abstract] [Full Text] [Related]

  • 17. Clinical and pathological characteristics and outcomes of Chinese patients with primary anti-neutrophil cytoplasmic antibodies-associated systemic vasculitis with immune complex deposition in kidney.
    Yu F, Chen M, Wang SX, Zou WZ, Zhao MH, Wang HY.
    Nephrology (Carlton); 2007 Feb 15; 12(1):74-80. PubMed ID: 17295665
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.